Literature DB >> 11246063

Isolated diastolic heart failure as a cause of breathlessness in the community: the Arbroath study.

R J MacFadyen1, C M MacLeod, P Shiels, W Russell Smith, T M MacDonald.   

Abstract

The aim of this study was to examine the prevalence of exercise limitation due to diastolic heart failure among patients felt to have cardiac breathlessness by their general medical practitioner but not referred to hospital. We found that 18% of patients had a simple investigated profile compatible with isolated diastolic dysfunction as a cause of their symptoms. Symptoms appeared to pre-date major cardiac events (infarction; stroke; arrhythmia) that dominated the subsequent clinical course. The patients in this group have adverse cardiovascular risk profiles. Obesity was a common co-morbidity which may impair detailed 2-D echocardiographic assessment.

Entities:  

Mesh:

Year:  2001        PMID: 11246063     DOI: 10.1016/s1388-9842(00)00153-7

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  5 in total

1.  Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.

Authors:  M D Thomas; K F Fox; D A Wood; J S R Gibbs; A J S Coats; M Y Henein; P A Poole-Wilson; G C Sutton
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition?

Authors:  G Yip; M Wang; Y Zhang; J W H Fung; P Y Ho; J E Sanderson
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

Review 3.  Current clinical applications of spectral tissue Doppler echocardiography (E/E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function.

Authors:  Stephane Arques; Emmanuel Roux; Roger Luccioni
Journal:  Cardiovasc Ultrasound       Date:  2007-03-26       Impact factor: 2.062

4.  The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.

Authors:  Van Kimmenade
Journal:  Biomark Insights       Date:  2007-02-07

5.  A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.

Authors:  Hari K Parthasarathy; Burkert Pieske; Marianne Weisskopf; Chris D Andrews; Patrick Brunel; Allan D Struthers; Thomas M MacDonald
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.